Related Experiment Videos
Laboratory diagnosis in thyroid auto-allergic diseases.
Allergologia Et Immunopathologia
|January 1, 1986
Summary
Thyroid autoallergic disease diagnosis can be improved by assessing both antibody levels and cellular immune responses. Combining antibody testing with leukocyte migration tests enhances diagnostic accuracy for thyroid autoimmune conditions.
Area of Science:
- Immunology
- Endocrinology
- Pathology
Background:
- Percutaneous biopsy is a primary diagnostic tool for thyroid autoallergic disease, but carries a risk of sampling error.
- Humoral and cellular immunologic sensitization are known parameters in thyroid autoimmunity.
- Existing diagnostic methods may not fully capture the complexity of immune responses in thyroid disease.
Purpose of the Study:
- To evaluate humoral and cellular immunologic sensitization in thyroid autoallergic disease.
- To compare the diagnostic utility of antibody determination and leukocyte migration tests.
- To assess the combined relevance of these immune parameters for diagnosis.
Main Methods:
- Determination of thyroid antimicrosomal antibodies using hemagglutination.
- Leukocyte inhibition migration tests using a microsomal antigen.
- Assessment of both humoral and cellular immune responses in patients with thyroid autoimmune disease.
Main Results:
- Both humoral (antibody levels) and cellular (leukocyte migration) sensitization are relevant in thyroid autoallergic disease.
- These immune responses can occur independently or concurrently in patients.
- Antibody determination is highly useful for diagnosis, with leukocyte migration tests serving as a valuable follow-up when antibody results are negative.
Conclusions:
- Assessing both antibody levels and cellular immune responses provides a more comprehensive diagnostic approach for thyroid autoallergic disease.
- The combination of hemagglutination and leukocyte inhibition migration tests can improve diagnostic confirmation.
- Leukocyte migration tests are particularly useful for confirming diagnoses when antibody tests yield negative results, reducing reliance on potentially inaccurate biopsies.